Latest filing published 09 Jun 2026 for Cryoport, Inc..
Linda Baddour's 11 sales total EUR 34.5 million, with a median of EUR 3,567,699, and the three largest are all at PRA Health Sciences, Inc.: EUR 7,435,911 on April 17, 2017, EUR 6,356,262 on August 14, 2017 and EUR 4,738,335 on January 16, 2018. No purchase appears.
The record holds 43 filings, published from March 4, 2016 to June 9, 2026, across three companies: PRA Health Sciences, Inc. (18 filings, Executive VP & CFO), Waters Corp /DE/ (15, Director) and Cryoport, Inc. (10, Director). It includes 17 grants and 15 option exercises.
The year 2016 is the busiest (9 filings), followed by 2017 and 2021 (6 each). The years 2019 and 2020 hold only one each. Three filings fall in the last twelve months, with no market trade. The median publication delay is 2 days.
At PRA Health Sciences, 5 of Baddour's trades fall within 30 days of a trade by Colin Shannon, 5 of David W. Dockhorn and 3 of KKR PRA Investors L.P., in the same direction. At Waters, 2 are close to those of Michael J. Berendt.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 43 declarations